Sauna Bathing to Improve Vascular Health of Adults With Heart Disease

October 27, 2023 updated by: Daniel Gagnon, Montreal Heart Institute

Effects of Sauna Bathing on Cerebrovascular Function in Middle-aged to Older Adults With Heart Disease

This study is a clinical trial that will determine if sauna bathing improves blood vessel health in adults aged 50-70 years with heart disease.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Mounting evidence suggests that heat therapy may improve cardiovascular health. Recent analyses of a large cohort of middle-aged to older Finnish men have established that frequent sauna bathing is associated with a reduced risk of cardiovascular mortality, of developing dementia and Alzheimer's disease, and of developing hypertension. Given the observational nature of these relationships, it remains unknown if the beneficial effects of sauna bathing can be directly attributed to heat exposure.

The objective of this study is to test the primary hypothesis that 8 weeks of sauna bathing improves flow-mediated dilation, a measure of blood vessel health, in middle-aged to older adults (50-70 yrs) with stable coronary artery disease.

Study Type

Interventional

Enrollment (Actual)

61

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montréal, Quebec, Canada, H1T1N6
        • Cardiovascular Prevention and Rehabilitation Centre of the Montreal Heart Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. A history of angiographic coronary disease: ≥70% arterial diameter narrowing of at least one major epicardial coronary artery and/or prior coronary revascularization and/or documented prior acute coronary syndrome and/or perfusion defect during exercise testing or pharmacological stimulation
  2. Stable medication doses (≥4 weeks) prior to enrolment
  3. Body mass index <35 kg/m2

Exclusion Criteria:

  1. Recent (<3 months) coronary artery disease-related hospitalization or change in angina pattern
  2. Unstable angina
  3. Ejection fraction <40% and/or clinical evidence of heart failure
  4. Significant valvular heart disease
  5. Uncontrolled hypertension (>180/110 mmHg)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Participants randomized to the control condition will be asked to maintain their normal daily habits.
Experimental: Sauna
The sauna intervention will consist of 20 to 30 minute sauna bathing sessions within a dry Finnish sauna, performed 4 times per week.
Sauna bathing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Flow-mediated dilation
Time Frame: Change from baseline after 8 weeks
Brachial artery flow-mediated dilation in response to 5 minutes of forearm occlusion
Change from baseline after 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-occlusion reactive hyperaemia (AUC)
Time Frame: Change from baseline after 8 weeks
Vascular conductance area-under-the-curve during reactive hyperaemia induced by 5 minutes of forearm occlusion
Change from baseline after 8 weeks
Post-occlusion reactive hyperaemia (Peak)
Time Frame: Change from baseline after 8 weeks
Peak vascular conductance during reactive hyperaemia induced by 5 minutes of forearm occlusion
Change from baseline after 8 weeks
Local skin heating-induced vasodilation
Time Frame: Change from baseline after 8 weeks
Plateau of the cutaneous vascular conductance response during local heating of the skin to 39°C
Change from baseline after 8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure
Time Frame: Change from baseline after 8 weeks
Systolic blood pressure at rest
Change from baseline after 8 weeks
Central arterial stiffness
Time Frame: Change from baseline after 8 weeks
Carotid-femoral pulse wave velocity
Change from baseline after 8 weeks
Heart rate variability
Time Frame: Change from baseline after 8 weeks
Resting levels of heart rate variability
Change from baseline after 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 4, 2018

Primary Completion (Actual)

September 12, 2022

Study Completion (Actual)

September 12, 2022

Study Registration Dates

First Submitted

July 24, 2018

First Submitted That Met QC Criteria

August 3, 2018

First Posted (Actual)

August 8, 2018

Study Record Updates

Last Update Posted (Actual)

October 31, 2023

Last Update Submitted That Met QC Criteria

October 27, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on Lifestyle intervention

Subscribe